Haemophilus influenzae Type b Carriage among Young Children in Metropolitan Atlanta in the Context of Vaccine Shortage and Booster Dose Deferral-Reference-Cited by-同舟云学术

Haemophilus influenzae Type b Carriage among Young Children in Metropolitan Atlanta in the Context of Vaccine Shortage and Booster Dose Deferral

Published:2011-12 Issue:12 Volume:18 Page:2178-2180
ISSN:1556-6811
Container-title:Clinical and Vaccine Immunology
language:en
Short-container-title:Clin Vaccine Immunol

Author:

Thomas Jennifer Dolan¹,Jackson Michael L.¹,Sharma Dolly²³,Mair Raydel¹,Bach Michelle C.¹⁴,Castillo Dana¹,Ejigiri O. Grace¹,Satola Sarah²⁵⁶,Cohn Amanda C.¹,Jerris Robert²³,Jain Shabnam²³,Farley Monica M.²⁵⁶,Mayer Leonard W.¹,Messonnier Nancy E.¹

Affiliation:

1. Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Atlanta, Georgia 30329

2. Emory University School of Medicine, 2015 Uppergate Drive, NE, Atlanta, Georgia 30322

3. Children's Healthcare of Atlanta, 1405 Clifton Road, NE, Atlanta, Georgia 30322

4. Biology Department, Agnes Scott College, 141 E. College Avenue, Decatur, Georgia 30030

5. Veterans Affairs Medical Center, 1670 Clairmont Road, Decatur, Georgia 30033

6. Georgia Emerging Infections Program, Atlanta VA Medical Center, 1670 Clairmont Road, Station 151, Decatur, Georgia 30033

Abstract

ABSTRACT Short-term deferral of the Haemophilus influenzae type b (Hib) vaccine booster dose during a recent U.S. Hib vaccine shortage did not result in widespread Hib carriage in Atlanta, as the Hib carriage rate was found to be 0.3% (1/342). Hib colonization was significantly more common among males and day care attendees.

Publisher

American Society for Microbiology

Subject

Microbiology (medical),Clinical Biochemistry,Immunology,Immunology and Allergy

Link

https://journals.asm.org/doi/pdf/10.1128/CVI.05254-11

Reference13 articles.

1. Progress toward elimination of Haemophilus influenzae type b disease among infants and children—United States, 1987–1995;Centers for Disease Control and Prevention;MMWR Morb. Mortal. Wkly. Rep.,1996

2. Interim recommendations for the use of Haemophilus influenzae type b (Hib) conjugate vaccines related to the recall of certain lots of Hib-containing vaccines (PedvaxHIB and Comvax);Centers for Disease Control and Prevention;MMWR Morb. Mortal. Wkly. Rep.,2007

3. Continued shortage of Haemophilus influenzae type b (Hib) conjugate vaccines and potential implications for Hib surveillance—United States, 2008;Centers for Disease Control and Prevention;MMWR Morb. Mortal. Wkly. Rep.,2008

4. Updated recommendations for use of Haemophilus influenzae Type b (Hib) vaccine: reinstatement of the booster dose at ages 12-15 months;Centers for Disease Control and Prevention;Morb. Mortal. Wkly. Rep.,2009

5. DolanJ. M.. 2010. Real-time PCR assays for the detection of H. influenzae serotypes a, b, and f and sequencing of the capsule biosynthesis operons of serotypes c, d, and e, abstr. C-1589. Abstr. 110th Gen. Meet. Am. Soc. Microbiol. American Society for Microbiology, Washington, DC.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. U.S. vaccine and immune globulin product shortages, 2001–15;American Journal of Health-System Pharmacy;2017-11-15

2. Evaluation of Haemophilus influenzaetype b carrier status among children 10 years after the introduction of Hib vaccine in Brazil;Memórias do Instituto Oswaldo Cruz;2015-09

3. Cultivation of an Adaptive Domestic Network for Surveillance and Evaluation of Emerging Infections;Emerging Infectious Diseases;2015-09